Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02563990 · ClinicalTrials.gov registry record · NA
Injection Pressure & Adductor Canal Block
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02563990: Clinical Trial NA study, sponsored by University of Miami.
NCT02563990 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02563990, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This is a prospective, randomized, single-blinded human clinical trial that will examine how injection pressure influences the spread of a given volume of injectate in the adductor canal, during adductor canal nerve block.
Primary Outcome
Our primary endpoint is the spread of injectate, defined as the distance between the uppermost and lowermost limits of spread of local anesthetic as assessed by ultrasound.
Interventions
- PROCEDURE High Pressure Injection
- PROCEDURE Low Pressure Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-12-03 |
| Est. Completion | 2016-12-09 |
| Phase | NA |
Why NCT02563990 stopped before completion
NCT02563990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which High Pressure Injection is the first listed.
NCT02563990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02563990 about?
NCT02563990 is a clinical study titled "Injection Pressure & Adductor Canal Block". This is a prospective, randomized, single-blinded human clinical trial that will examine how injection pressure influences the spread of a given volume of injectate in the adductor canal, during adductor canal nerve block.
What is the current status of trial NCT02563990?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2015-12-03. Estimated completion is 2016-12-09.
What interventions are being tested in trial NCT02563990?
The interventions under investigation include: High Pressure Injection (PROCEDURE), Low Pressure Injection (PROCEDURE).
Who is sponsoring clinical trial NCT02563990?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02563990's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI